









Markets
/
Stocks
/
nasdaq-mltx
/

MoonLake Immunotherapeutics

MLTX

View Detailed Chart

52.920USD

+2.480+4.92%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

3.36BMarket Cap

LossP/E TTM



MoonLake Immunotherapeutics

52.920

+2.480+4.92%

Overview Company Financials

Financials

Intraday

30m

Today

+4.92%

5 Days

-3.90%

1 Month

+8.24%

6 Months

+21.24%

Year to Date

-2.27%

1 Year

+28.20%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 16 analysts

STRONG BUY

Current Rating

77.071

Target Price

45.64%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

MoonLake Immunotherapeutics

MLTX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(4)

Buy(7)

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.922

Neutral

RSI(14)

57.740

Neutral

STOCH(KDJ)(9,3,3)

49.286

Neutral

ATR(14)

2.506

High Vlolatility

CCI(14)

-44.652

Neutral

Williams %R

39.982

Buy

TRIX(12,20)

0.610

Sell

StochRSI(14)

47.172

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

52.128

Buy

MA10

53.362

Sell

MA20

51.717

Buy

MA50

47.258

Buy

MA100

42.932

Buy

MA200

45.502

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.

Ticker SymbolMLTX

CompanyMoonLake Immunotherapeutics

CEODr. Jorge Santos Da Silva

Websitehttps://moonlaketx.com/